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A NOTE FROM ROSS HALL

W

elcome to our Spring 2017 edition.

I am incredibly proud of our students
and trainees. They are a diverse, altruistic,
exceptionally bright group who came to the George
Washington University (GW) School of Medicine and Health
Sciences (SMHS) to grow professionally and personally. Now,
as we prepare to transition from one academic year to the next,
I want to congratulate our outstanding graduates. I am proud
of everything they have accomplished.
I’ve always felt enormous pride in being an alumnus and
faculty member of SMHS. No, we don’t have a football team,
and our sports teams don’t always draw national attention.
However, I know that I received a great medical education and
residency training at GW. And as dean, I know that we have
an amazing group of talented and dedicated faculty and staff.
I am unbelievably proud of them and the work that they do
to make a difference in our students’ and patients’ lives; in the
community; and, by advancing knowledge, in medicine at large.
The school’s reputation for creating tomorrow’s health
professionals, advancing research, providing high-quality

care, and effecting change in our local, national, and global
communities has never been higher. When you read these
stories touching on each aspect of our mission, I hope you share
the same sense of pride as our students.
As the university moves closer to completing its Making
History fundraising campaign, and as President Steven Knapp
concludes his tenure here, I hope that your pride in SMHS
leads you to make a gift to support our mission of being a
world-class academic medical center. Our students and faculty
who benefit from your philanthropy will be eternally grateful.

JEFFREY S. AKMAN, M.D. ’81, RESD ’85
VICE PRESIDENT FOR HEALTH AFFAIRS
WALTER A. BLOEDORN PROFESSOR OF ADMINISTRATIVE MEDICINE
AND DEAN, SCHOOL OF MEDICINE AND HEALTH SCIENCES
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MAKING THE ROUNDS
Lt. Gen. West
Addresses Graduates
Lt. Gen. Nadja West, M.D. ’88, will
serve as keynote speaker at the George
Washington University School of
Medicine and Health Sciences M.D.
program diploma ceremony on May 21.
West is the 44th surgeon general
of the United States Army and
commanding general, U.S. Army
Medical Command.
She has served in a variety of leadership positions and has commanded
at the Army Community Hospital, Army
Medical Center, and Regional Medical
Command levels. Before being named
surgeon general, she served as the U.S.
Joint Staff surgeon.
West will receive an honorary
degree of doctor of public service at
GW’s 2017 Commencement on the
National Mall.

MFA Welcomes New CEO
George Washington University (GW) Medical Faculty
Associates (MFA) recently selected Robert E. Kelly, M.D., to
serve as CEO of the clinical enterprise. In this role, he will
provide leadership and strategic physician enterprise integration, as well as overall operational management for the
organization. Kelly brings to GW decades of both clinical and
administrative experience, most recently serving as president and chief operating officer of New York-Presbyterian
Hospital, and as a faculty member of Weill Cornell College of
Medicine since 1985.
As CEO, Kelly will partner with Anton Sidawy, M.D.,
M.P.H. ’99, president and chair of the Board of Trustees at the
GW MFA, and Lewis B. Saltz Professor and Chair of Surgery
at the GW School of Medicine and Health Sciences, and
other key members of the GW MFA community to further
develop and implement the organization’s mission and strategic vision.
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Day in the Life
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1

Match Day
1 Marcus Mitchell welcomes an embrace

after learning he has matched in his top
choice for anesthesiology: the University
of Maryland Mercy Medical Center and
Johns Hopkins Hospital.
2

Olivia Beaubrun, left, and Theiju

Sebastian, right, smile for the camera after
opening their envelopes to see where
they’ve matched: St. Louis Children’s

of Medicine, laughs at the reaction from
family and friends after showing them her
letter.

Follies

Day in the Life
7 First-year medical student — but almost

a doctor! — Vinay Rao stands with his family
at the kickoff to “Day in the Life,” a biennial event when M.D. students’ family and

4 Fourth-year medical students bid Auf

friends participate in a white coat cere-

Wiedersehen — with lyrics tweaked to

mony, interactive sessions and discussion

better suit a medically inclined audience

groups, and a diploma ceremony.

— during Follies, the annual student-run
program of skits, dances, and songs.

8

Juliet Lee, M.D., assistant professor

of surgery at SMHS, helps an SMHS

Hospital and Yale University New Haven

5 The M.D. Class of 2017 celebrates the

family member perform proper CPR

Hospital, respectively. “This is way more

end of their final Follies with an eye toward

technique during “Code Blue,” one of

emotional than I could’ve imagined,” said

the future: the institutions where they will

several sessions offered to Day in the Life

Sebastian, who matched in pediatrics, as

complete their residencies.

participants.

did Beaubrun. “It’s the best day ever.”

Third-year M.D. students Christina

9 Day in the Life participants get a true

3 Cristina Zottola, right, who matched in

Canini, left, and Omid Manoochehri,

taste of what medical students regularly

obstetrics and gynecology at Lenox Hill

right, have a spirited debate over Suzanne

face: an exam.

Hospital with Hofstra Northwell School

Arnott, who awaits a decision.

6
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MAKING THE ROUNDS

Research Days Showcase Breadth and Depth of Student Endeavors
On the second day of the 22nd annual
George Washington University (GW)
Research Days, School of Medicine and
Health Sciences (SMHS) students had a
chance to show off their work outside
the classroom to their peers and the
GW community.
“That’s the fun part [of Research
Days],” second-year M.D. student
Sharjeel Chaudhry said of seeing his
classmates’ research projects. “It’s a

great way to make a new connection,
just from understanding someone’s
research and talking with them
about it.”
Chaudhry presented his work as
a winner of the William H. Beaumont
Research Award, as did first-year
M.D. students Brendan Campbell
and Lauren Jacobs. The new tradition began last year when the editors
of Fusion, the William H. Beaumont

Medical Research Honor Society’s
student-led publication, decided
to give students the opportunity to
present their research.
In addition, more than 200
SMHS students presented posters at
the event.
To download a copy of the most
recent edition of Fusion, visit smhs.gwu.
edu/research/publications/fusion.

Putting Health Care on Center Stage:
Standing on the stage in George Washington University’s
(GW’s) Jack Morton Auditorium in February, Sens. Bernie
Sanders (D-Vt.) and Ted Cruz (R-Texas) debated the state of
the U.S. health care system.
Although the lawmakers did not agree on much
throughout the debate, they were able to have a frank and
open discussion about the Affordable Care Act’s future.
“It was nice and refreshing for neither side to be yelling,
but simply stating the facts and their positions,” said John
Marin, a first-year M.D. student at GW. “I definitely appreciate GW holding all these talks.”
During the almost two-hour debate, Cruz and Sanders
spoke about the role of the government in health care and
the future of Medicare.

4
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Service and Leadership

Taking Home the Golden Apple

Sara Melita was recently selected to serve as the senior
advisor and chief of staff to Jeffrey S. Akman, M.D. ’81, RESD
’85, vice president for health affairs, Walter A. Bloedorn
Professor of Administrative Medicine, and dean of the GW
School of Medicine and Health Sciences (SMHS). In her new
role, she’ll work with the SMHS senior leadership team to
advance Akman’s vision and priorities for the school.
Melita brings 20 years of senior leadership and advisory
experience to the post, a decade of which has come at
GW. In that time, she served as the assistant vice president for organizational development and effectiveness,
where she focused on building effective teams
and improving performance throughout GW. More
recently, she was a senior advisor to GW’s senior leadership team, working across schools and divisions to
develop annual and strategic goals aligned with mission
priorities. She also was involved in the development and
implementation of GW’s Vision 2021 Strategic Plan.

Every year, medical and physical therapy students vote on
the educators who have had a significant impact on their
education; the 2017 Golden Apple Award recipients were
Zhiyong Han, Ph.D., associate professor of biochemistry and
molecular medicine; Marie Almira-Suarez, M.D., assistant
professor of pathology; Kristin Gorelik, M.D.,
assistant professor of obstetrics
and gynecology; Kathleen
Calabrese, M.D. ’08, assistant
professor of emergency
medicine; Holly Jonely,
D.P.T., assistant professor
of physical therapy and
health care sciences; and
Margaret Plack, D.P.T.,
Ed.D., professor of physical
therapy and health care
sciences.

THE CAMPAIGN FOR GW
SCHOOL OF MEDICINE &
HEALTH SCIENCES

Support the School
of Medicine &
Health Sciences
By advancing our four-part mission — to teach, heal,
discover, and serve — GW’s School of Medicine and
Health Sciences (SMHS) seeks to change lives and
advance society.
SMHS is part of the George Washington University‘s
$1 billion philanthropic campaign, which supports
students, enhances academics, and breaks new
ground through capital projects and research.
Your gift enables SMHS to have an impact in the
community, the country, and the world.

Join us in making history
go.gwu.edu/makehistorysmhs

Capital campaign_4617.indd 1

4/6/17 9:25 AM
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UNDER A
NEW UMBRELLA
B

BY CAROLINE TRENT-GURBUZ
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rent Etiz, a Stanford graduate and former Silicon
Valley techie, was in need of a change. “I had this
period of enlightenment,” he says, “where I thought
‘I really want to go back and try [becoming a doctor],’
so I started scouring the country for programs that offered all
of the premedical requirements.” The George Washington
University (GW) School of Medicine and Health Sciences
(SMHS) Post-Baccalaureate Pre-Medicine program fit the bill.
The program, designed to prepare college graduates with
the prerequisites for admission, has long attracted highfliers
like Etiz, successfully guiding them into medical school.
Likewise, another SMHS program, Medical Laboratory

Sciences (MLS) — a combination of
blended (a mixture of online and bricksand-mortar courses) and graduate
programs — has drawn ambitious
students interested in ascending to the
next step in their career.
“I love the program,” says Brandy
Holzman, an MLS student. After
riding in a hunter/jumper horse show
circuit until she was 28, Holzman felt
she “needed to find a career that doesn’t
involve horses.” Tired of traveling and
suffering from back pain, she began
working in an animal hospital, with an
eye toward shifting to the human side of
health care. “I felt too old [for medical
school], so this [program] was a nice
balance; I can be well-rounded and help
with the diagnostic work and still talk to
doctors. It seemed like a good fit for me.”
With the success of the MLS and
Post-Baccalaureate Pre-Medicine
programs — both of which fell under
the Clinical Research and Leadership
umbrella within Health Sciences — came
expansion. When GW started to build
out the Virginia Science and Technology
Campus (VSTC) in Ashburn, Virginia,
an opportunity presented itself: The
two programs were shuffled under the newly established
Department of Integrated Health Sciences, led by interim chair
Marcia Firmani, Ph.D., M.S.P.H., and relocated to the VSTC.
“We’re able to have dedicated staff at the VSTC to advise
on these programs and have people doing outreach specifically
for these programs,” says Firmani, who also serves as director
of the MLS blended bachelor of science in health sciences
(B.S.H.S.) and graduate programs and as assistant professor
of integrated health sciences at SMHS. “For everyone in the
department, their home is at VSTC. The benefit is, we now
have that common ground that provides better opportunities to
work together to expand the existing programs while building
new programs.”
The new department also includes distance-learning
opportunities — a fully online B.S.H.S. with a major in MLS for
medical lab technicians, five certificate programs, five graduate
programs, and numerous military-affiliated programs — and
future educational possibilities.
“We’re in the process of developing dual-degree programs,
and we are in the planning stages of a potential doctoral degree
program to expand upon our current career pathway options
at VSTC,” Firmani says. “There are a lot of opportunities for

growth, teamwork, and spearheading new endeavors, which is
an exciting movement to be involved in.”
Holzman says that having access to the VSTC campus for
her program, which blends online coursework with on-site lab
training, has been ideal. “I was scared at first, because I’ve never
done online courses, but it’s worked out well,” she says. “Having
a lab in Ashburn is great because I still have that contact
between professor and student.”
Kenia Gomez, who’s in her last semester in the blended
MLS program, has also found that the class structure suits her
needs. “What I like about the program is that the laboratory
class covers the same material being taught online,” she
explains. “[It] helps me understand the course material and the
science behind it more.”
Etiz, when he’s not preparing for the MCAT with his
cohort, has also taken advantage of what the VSTC offers.
“Because there’s the MLS program, there’s also a research
laboratory out of the Virginia campus, so I had the opportunity
to assist in research with Dr. Marcia Firmani,” he says. “To
be able to have those opportunities while also completing my
didactic work … ultimately made coming to GW a very easy and
intuitive decision.”
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n August 2016, members of the George Washington
University (GW) Hospital anesthesia team — including
Samantha Brackett, who was just one month into her
first year of residency — were waiting on standby in the
interventional radiology (IR) suite. Their patient had presented
to the Emergency Department with severe abdominal pain, but
was stable enough to move to the IR suite for a procedure to
embolize a ruptured vessel, the source of the problem.
Suddenly, recalls Brackett, “the patient experienced an
acute intra-abdominal hemorrhage from the rupture of this
vessel, and became very unstable. We were immediately able
to secure the airway as well as manage the massive blood
loss and critical situation that was unfolding. Immediately
after intubating, I began to notice certain changes that are
characteristic of MH.”
Brackett explains in lay terms that MH, or malignant
hyperthermia, is a rare genetic disorder that causes a defect in
a type of skeletal muscle receptor. When certain anesthetic
agents, such as inhaled anesthetics and succinylcholine, a
neuromuscular blocking drug, interact with the receptor, a
biochemical chain reaction occurs.

“[The body] generates excessive heat that actually breaks
down the muscle cells,” Brackett explains. “You can have
pretty catastrophic damage. It’s key that you treat it early,
and even minutes in treatment delay will increase morbidity
and mortality.”
With the clock ticking, Brackett noted key signs of the
disorder — increased exhaled carbon dioxide, increased heart
rate and temperature, and muscle rigidity — and ran through
the checklist of possible diagnoses in her head. The habit was
one she had performed during an MH simulation just a few
days earlier in the Clinical Learning And Simulation Skills
(CLASS) Center at the GW School of Medicine and Health
Sciences (SMHS) — a striking coincidence given that most
anesthesiologists never see MH in their entire career, let alone
within the first weeks of their residency.
“In all of the years I’ve been practicing, getting close to 20
years, I’ve never had a patient with MH, ever — that’s how rare
it is,” says Marian Sherman, M.D. ’99, assistant professor of
anesthesiology and critical care medicine at SMHS. “But you
talk about it every year in training, you talk about it on every
standardized exam you ever take as an anesthesiologist. It’s

GWMEDICINEHEALTH.COM
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definitely one of those clinical scenarios that’s high stakes, and
you’d better know what to do with it because it’s our specialty.”
It’s for those reasons that anesthesiologists regularly train
for cases like MH. For residents, however, simulating such
a critical disorder not only incorporates minor simulation
exercises, such as inserting an IV or arterial line, but also team
training and communication skills.
“When you’re doing high-stakes drills, like an MH drill, you
don’t want one person doing everything,” Sherman says. “You
want one person to lead the drill, you want to recognize people’s
skills and abilities and assign tasks to each person, and create
conversation between the participants so that you can intervene
most comprehensively in these crises. As always, the earliest
determination of what’s wrong relates to better patient outcome.”

10
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It’s that type of training in which the SMHS CLASS
Center excels. “You learn better when you do it yourself,” says
Claudia Ranniger, M.D., Ph.D., director of the simulation
center and assistant professor of emergency medicine at SMHS,
“and we don’t let you leave having failed.”
What’s key, both Ranniger and Sherman say, is that the
CLASS Center is a safe learning environment. Depending on
the scenario, both residents and medical students, as well as
nurses from GW Hospital, can practice their skills — whether
with manikin Victoria in the labor and delivery suite; with
another manikin, Hal, in one of two operating rooms; or in the
high-fidelity rooms and the procedural skills lab — without
worrying about negatively affecting patient outcomes.
“It’s great to have a responsibility that you usually don’t get to

From left to right, Marian Sherman, M.D.;
Asheesh Kumar, M.D.; Marianne David, M.D.;
Samantha Brackett, M.D.; Raymond Pla, M.D.;
and Hank Allen, M.D.

practice and to test yourself in a safe environment,” Ranniger says.
Rooms are set up as realistically as possible, with the
kind of equipment students and residents would see in GW
Hospital. Depending on the scenario, learners may know
various details and operate accordingly; in other cases, students
will go in without any information.
“The subject matter almost gives away what’s important in
the exercise, which is identifying variables and coming up with a
broad differential diagnosis, and then making smart, informed
interventions,” Sherman says. “We might give them a little bit of
information, like ‘the patient you’re taking care of is a 40-year-old
person who has a history of asthma and had a knee scope under
epidural anesthesia in the past. You’re taking care of this patient
now. The patient’s in the OR, ready for induction of anesthesia.’ ”

In Brackett’s simulation, there was scant contextual
information. “We knew that the scenario would involve a type
of anesthetic crisis; we just didn’t know what type of emergency
we were going to deal with,” she recalls. “Our scenario involved
a young, healthy patient having a fairly low-risk surgical
procedure. The case began at the time of induction of general
anesthesia in the operating room.”
It was then that she ran through possibilities in her head,
an ability that was strengthened with practice. “What, in
particular, the anesthesiologists do when they ‘sim’ with their
residents, is to say ‘come up with a differential diagnosis in your
head for all the things it could be, no matter how improbable,’ ”
Ranniger explains. “Unless you do that, you won’t think of
it when it really happens. It keeps you engaged in care of
the patient and thinking ahead, and that’s really what’s so
important to prevent adverse outcomes: to see it coming, not
wait until it happens and recognize it.”
With her simulation team, Brackett considered potential
diagnoses before settling on the correct one and shifting to
the debriefing session, arguably the most important part of the
simulation exercise. Because the CLASS Center simulation
rooms are equipped with audio and video recording, debriefing
participants can review their performance, learn the consequences
of misdiagnosis, and reflect on their diagnostic process.
“There’s no better way to learn than to have followed
your line of thinking and get the wrong clinical consequence,
because every single simulation session we do is followed
immediately by a debriefing session,” Sherman says. “Some
people have an image of what they look like or what they’re
doing in a scenario, but if they’re anxious and they’re hanging
back, you can see that when you do the video recap. A simple,
gentle suggestion like ‘move in next time’ [works] because when
you’re in closer to the patient, the whole team knows you’re
there, your hands are ready to work.”
That kind of encouragement directly feeds into students’
and residents’ performance when in a real-world situation. In
Brackett’s case, as the team tackled their patient’s care in the
IR suite, she mentally ran through the differential diagnoses,
“picking it up, I think immediately, because I had in the back of
my head that I had just experienced it and I knew it was such a
potentially devastating diagnosis.”
Brackett relayed her suspected diagnosis to the other
anesthesiologists, an act of considerable courage. “For a firstyear resident to say ‘I think this patient’s resuscitation might be
complicated by a case of MH’ [was brave] — she said it a couple
of times, and I really applaud her for having the confidence to
say again that something isn’t right here,” Sherman notes.
Brackett, however, credits the diagnosis to her team. “I
had such a strong team around me,” she says. “That definitely
put me at ease, and we were able to effectively communicate
and successfully treat the patient.”
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Reamer Bushardt:

Cultivating Strengths
Within Health Sciences
BY KATHERINE DVORAK

R

eamer L. Bushardt, Pharm.D., P.A.-C., DFAAPA,
brings a wealth of expertise to his role as senior
associate dean for health sciences at the George
Washington University (GW) School of Medicine
and Health Sciences (SMHS). Bushardt is both a pharmacist
and a physician assistant (P.A.) with experience in caring for
underserved communities in rural areas of the Carolinas.
Bushardt earned a degree in pharmaceutical sciences and
a doctor of pharmacy from the University of South Carolina.
After practicing as a pharmacist in a cancer center, he trained
as a physician assistant at the Medical University of South
Carolina and practiced in rural primary care. Bushardt began
his career in academic medicine in the Palmetto State, but
he is no stranger to Washington, D.C. He serves as editor-inchief for the Journal of the American Academy of Physician
Assistants ( JAAPA), based in Alexandria, Virginia. Bushardt
says he regularly spent time between meetings learning about
and exploring the District.
“Through my editorial work and as a visiting scholar, I
met some of the faculty at GW, and I was really attracted to
the breadth and depth of their talents,” he says. “I’ve also had
a very strong interest in learning more about health policy and
about the innovative ways we can train health professionals
and health care researchers — [areas where] the GW
community is very much at the forefront.”
Although Bushardt is still setting up his office in Foggy
Bottom and adjusting to life in D.C., his vision for the future
of the dozens of health sciences academic programs at SMHS
is already forming. Here, he discusses his career path from
pharmaceutical science to higher education and his aspirations
for health sciences at GW.
Q: What is your vision for the future of health sciences at GW?
A: A vision for the future of health sciences is not
something I needed to create. It already lives within the
faculty, staff, and students across the health sciences programs.
My job is to help them realize their strengths and come
together as a diverse family of health sciences researchers
and educators. Health sciences hosts 45 different academic

12
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programs, and many are unique with regard to curricula and
program goals. Our health sciences students experience GW
very differently — some as residential learners in Foggy Bottom
or at the Virginia Science and Technology Campus (VSTC),
others from all over the world in online learning communities,
some within postgraduate programs in various hospital and
health systems, or even during active military service via
educational partnerships with the U.S. military. There is no
one educational paradigm for health sciences.
My challenge is to build a shared identity that leverages
our collective strengths. This challenge calls us to prioritize
and even more fully embrace interprofessionalism as a
value across every facet of what we do. It is about advancing
translational research and pioneering new and innovative ways
to prepare health care professionals. It is taking our combined
knowledge from practice, from policy, from research, from
public health, and from the classroom, and creating an
inventive approach to reach our goals — an approach that is
distinctively health sciences.
I really enjoy breaking silos and bringing together talent in
ways it might not naturally combine, so I am beyond excited to
be here at GW.
Q: What drew you to pharmacy?
A: Mentoring and apprenticing drew me to pharmacy.
My father is a community pharmacist and leader in that
profession, particularly in South Carolina. He worked for
40 years as a small-business owner. At age 10 or 11, I started

helping him in his drugstores. I loved the atmosphere. My
father is such a warm and incredibly kind person. He forged
incredible relationships with his patients, and humbly worked
behind the scenes to help them solve problems that got in the
way of healthier, productive lives. I aspired to be like him (I
still do, actually). My professional identity as a pharmacist
started forming well before I attended my first pharmacology
or therapeutics class.
Q: After earning your Pharm.D., you went on to train as a P.A.
What interested you in the P.A. profession?
A: My first job as a pharmacist was in a cancer center in
South Carolina, primarily working with socioeconomically
disadvantaged patients with cancer. There was a small group
of oncologists, and I was a clinical pharmacist embedded
with that team. I would support patients who developed
adverse effects to treatment or who were balancing chronic
medical issues along with their treatment for cancer. This
partnership with physicians and with patients felt very natural.
My physician colleagues were very focused on trying to cure
the patients from their cancer, and they welcomed my help
to address adverse effects or chronic medical illnesses. After
doing that for a little while, I wanted to advance my diagnostic
skills, and the P.A. profession really spoke to me. It offered me
what I felt I needed.
Q: Recently a new health sciences department was created at
the VSTC — the Department of Integrated Health Sciences. Do you see
more growth at VSTC in the future?
A: The VSTC is an incredible asset for the university and
region. This campus is a focus for much of our targeted growth
in health sciences. The synergy realized between schools with
VSTC-based programs is excellent. The School of Medicine
and Health Sciences has strong collaborations with the College
of Professional Studies and the College of Nursing, which both
maintain strong contingencies there as well.
As a newcomer to GW, I am thrilled to have the
opportunity to work in Northern Virginia, which is
surrounded by leading companies and forward-thinking
industries in technology and data management. The health
sciences team regularly meets with dynamic industry
executives there to learn about how their fields are evolving; to
talk with them about partnerships in workforce development
and innovation; and to explore new professions and lines of
study that can continue to stimulate advances in education,
research, and service. We are not trying to reinvent any wheels.
If you want to transform discoveries into products and services
that benefit society, then cultivating meaningful partnerships
between higher education and industry is the right move.
Q: What got you interested in being editor-in-chief of JAAPA?
A: I’ve always enjoyed writing. One of my grandmothers
was an English teacher, and during elementary and middle
school, I would go after school to spend time with my

grandparents. My grandmother would help me with my
homework, with special attention for any writing assignments.
She loved a red pen like any good English teacher, and I can
still see her fine, red cursive tightly positioned between my
original lines. Inadvertently, she offered me this boot camp
experience in writing.
When I took my first job in academia at the Medical
University of South Carolina as a … faculty member, I was
thrust into this space where writing grants and scholarly
articles was an expectation, and I enjoyed it. … I started peer
reviewing and writing for JAAPA, and the editor asked if I
would consider being a regular writer and part of the editorial
board, so I did that. When the editor-in-chief retired several
years later, I was approached about taking that position.
Q: What made you decide to pursue a career in academic
medicine, and what does it mean to you to play a role in the
education of future medical professionals?
A: Growing up in a rural, underserved community shaped
that desire. In my hometown, there were limited community
resources and a small number of health care providers, so
access to care was a problem. I did not have the context to
understand it when I was younger, but the tremendous amount
of health inequity there is very apparent to me now. Following
in my father’s career path as a pharmacist and subsequently
practicing as a P.A.-pharmacist in rural communities, I had a
personal desire to expand access to care. Rural primary care is
hard work, but it can be very fulfilling.
As faculty and an administrator in academic medicine,
I still strive to expand access to care and help patients and
families avoid the struggle to find a caring, capable provider.
This passion fuels my work in education and research. Over
the past several years, I have worked harder to help innovate
how care is delivered, so we can provide it more affordably,
more safely, and with better coordination. This pursuit also
involves leadership to help shape health policy and modernize
the regulatory environment so all health professionals can
practice to the full extent of their training and experience,
which I believe is a practical strategy to improve access,
lower the overall cost of care, and combat the current
geographic misdistribution of health care professionals in the
United States.
The talented students, dedicated staff, and passionate
faculty within SMHS give me enormous hope for the future.
I feel fortunate to be a part of such a distinguished university,
and am leveraging every opportunity to build collaborations
and benefit from the broad base of expertise in education and
research at GW. Washington, D.C., seems like a long way from
my beginning in rural South Carolina, but at the same time, it
already feels a lot like home.
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IN ACTION
BY CAROLINE TRENT-GURBUZ

Christian Hendrix,
first-year M.D. student

hristian Hendrix had just started her first year at
the George Washington University (GW) School
of Medicine and Health Sciences when she was hit
hard by the news: Within a matter of days, Philando
Castile and Alton Sterling had been shot and killed by police
officers.
“A couple of students and I came to class the following
Monday just feeling disconnected,” she recalls. “We had been
experiencing a lot of political talk about bigotry and dividing
the nation and doing harmful action against people just
because they’re different from you.”
Hendrix and a few friends talked to GW faculty
members and returned to class, sharing their
thoughts after the lesson had wrapped. “We had
so much support from the administration
and from everyone in the class, through
hugs and tears and solidarity.”
That support — and the desire to
speak up — spurred Hendrix to do
what so many other SMHS students
have done before her: act.

STUDENT ACTIVISTS

GW has a long history of activism and
advocacy — during the last several
decades, students have supported
HIV/AIDS research, measures for
patient outcomes, and efforts to provide
greater equity in health care, among other
issues — and that is precisely why many SMHS
students choose to attend school in the nation’s
capital. SMHS leadership has also sought to
continue to shape student activists.
“Every clinician needs to recognize that
[advocacy] is part of what their scope of practice
should be to be an excellent clinician in the 21st
century,” says Lawrence “Bopper” Deyton, M.D.
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’85, M.S.P.H., senior associate dean for clinical public health,
and professor of medicine at SMHS. “We take no position in
what we teach here on what students’ positions are or should
be. We just want students to know how to develop their own
viewpoints and be able to know how to advocate for their
viewpoints when they are practicing clinicians.”
Those perspectives may be dynamic, Deyton adds, but what’s
key is for students to embrace their passion. It’s a stance Grace
Henry, Ed.D. ’12, director of the Office of Diversity and Inclusion
and adjunct assistant professor of medicine at SMHS, echoes.
“We want a social activist, but we want these students to
recognize that the definition is crafted by themselves,” she says.
“I truly want this generation to realize that they don’t have to
be constrained by what they’ve seen activism to be, but that
they have the ability to define it and be as effective as they need
to be to make the change they want to see.”
As Henry explains, for some, activism means writing
letters, signing petitions, and calling representatives; for
others, it means organizing, marching, and putting a face on
an issue. In 2014, for example, M.D. program students held a
die-in for White Coats for Black Lives, a movement aiming
to eliminate racial discrimination in health care, in front of
the Foggy Bottom Metro station; in January 2017, the SMHS
Inclusion Group posed for photos with white boards displaying
messages of solidarity for #WhiteCoats4BlackLives.
“One thing I’m learning is that you can be involved in
many different ways,” Hendrix says. “Involved doesn’t mean
that you have to take on a visible, active role. Involved can be
little things; just voicing
awareness can be a small step
anybody can take.”

“As health practitioners, we see a lot that’s on
the ground … we can bring the perspective
of ‘coverage is good; coverage has helped;
coverage has been good for patients.’
Those are things we can see firsthand.”
				

– J amie Majdi,
third-year
M.D. student

John Marin,
first-year M.D. student

POLITICAL ACTION

Hendrix’s own steps came
in the form of organization.
She joined the SMHS
student-led Social Justice
Interest Group, which
focuses on inclusion,
solidarity through helping
those in need, and using
its voice to advocate for
patients.
The group also worked
with classmates who
added two chapters, one
for White Coats for Black
Lives and another for the
American Medical Student
Association, designed to promote medical student
activism. “The main thing we want to do is reduce health
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disparities,” Hendrix says. “We think one platform is through
social justice.”
With that platform in mind, Hendrix joined Protect Our
Patients, an Affordable Care Act anti-repeal campaign, and
helped organize a D.C.-based summit in early January 2017.
On Monday, Jan. 9, SMHS M.D. program students Jamie
Majdi, Camilla Maybee, Mariama Evans, and Rayna Sobieski
joined their fellow classmates and students from across the

country at the Department of Health and Human Services, and
together they marched on Capitol Hill, where they delivered
the #ProtectOurPatients petition to members of Congress and
their legislative aides.
“Because of our position as health care providers, we have a
moral imperative to advocate for patients,” says Majdi, a thirdyear M.D. student who met with aides for Sens. Dick Durbin
(D-Ill.) and Tim Kaine (D-Va.). “I truly think that if we were

“Change is only going to come when someone steps
up, says that something is a problem, and makes
their voice heard. I do think it’s really cool that even
as students, we have this ability to shape what the
future of physical therapy is going to look like, and
that’s a really powerful tool. It’s doing ourselves an
injustice and our future patients an injustice if we
don’t advocate and speak up to make our care the
highest quality it can be.”
– Sarah Guenzburger, second-year D.P.T. student

Sarah
Guenzburger,
second-year
D.P.T. student
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to look at health care policy in a reasonable and measured way,
everyone would agree that more coverage is best for the people
of the United States.”
SMHS Doctor of Physical Therapy (D.P.T.) students
have taken a similar approach to advocacy, participating in
the American Physical Therapy Association (APTA) Federal
Advocacy Forum in March 2017. The forum, says Annie
Golovcsenko, a second-year D.P.T. student, had an educational
bent, where participants, professionals, and students alike
heard different speakers “talk about the issues that our patients
are having to deal with and how we can be advocates for them,
not only in the health care field, but also on Capitol Hill to
our legislators.”
“It was a great time to talk to other P.T.s and P.T. students
about ways to get involved and to advocate for our patients, and
also figure out the most effective way to go about talking to
our representatives,” Golovcsenko explains. “The APTA has a
clear process to support us doing this; they were there giving us
advice and tips to go about it.”
That approach to advocacy — speaking to representatives
and voicing patients’ needs — is why third-year SMHS M.D.
student Ashtin Jeney took action to ensure sure she has a “seat
at the table.”
“It’s one thing to be vocal, it’s one thing to have an
opinion, and it’s one thing to care about issues,” Jeney says, “but
putting yourself at the table, with the people who are having
the conversation to enact change, I think, is really where we
have to [be].”

“Just being in D.C. and having so many
faculty members in the leadership roles of
professional organizations like the AAPA
[American Academy of Physician Assistants] …
I think [it gives us] a great responsibility to be
advocates for the profession.”
– Ellie Frye, first-year P.A. student

Jeney is the sole student representative on the bipartisan
American Medical Association Political Action Committee
(AMPAC) board. While the board works to make sure
physicians’ voices are heard in policy and supports candidates
who prioritize health-related issues, Jeney’s role is more
concentrated: she raises awareness of AMPAC’s mission by
reaching out to students. It’s an opportunity that could only
have opened up at GW, she says.

“The Healing Clinic definitely makes you think
creatively. … [L]earning to navigate barriers to
care that aren’t taught in the classroom is a
unique opportunity that only the Healing Clinic
can provide.”
– Kirsten Almagro, first-year P.A. student

At GW, “there are so many opportunities to get involved
in policy, not just through our curriculum and the great things
that we’ve gotten to do with the new [clinical public health
theme] … but also to get involved in different organizations
here in D.C.,” she explains.

FACE-TO-FACE WITH PATIENTS

One inspiring organization has been the Healing Clinic, an
SMHS student-run free clinic founded in 2006 that is open to
the community.
“The Healing Clinic is a great way for people who want
to get involved to, in a very direct way, help people and take
care of patients,” says John Marin, a first-year M.D. student at
SMHS and director of communications for the Healing Clinic.
The clinic, which has two locations, one in Prince Georges
County, Maryland, and another at Bread for the City in the
District, is made up entirely of student, resident, and clinician
volunteers.
“Being able to simultaneously give back to the community
while working on our patient interaction and physical exam
skills is so valuable,” says first-year physician assistant (P.A.)
student Bailey Ernstes. “I can’t tell you how many times I’ve
heard a classmate who’s been at Healing Clinic say ‘I’m so glad I
went to that; it reminds me of why I want to do this.’ ”
The P.A. students, like their M.D. and D.P.T.
counterparts, draw particular inspiration from working with
patients in the community, and their volunteer efforts have
extended to other groups, such as the SMHS DC Health and
Academic Prep Program, which exposes rising high school
seniors to health care professions. They also regularly advocate
for their profession — P.A. students in 2015 spoke to Congress
about P.A. research funding, diversity, and student loan
repayment programs — and they take a class specifically on the
role physician assistants play in health care.
“It was an eye-opening course for everyone,” says Ernstes.
“I didn’t realize there was so much advocating that still needed
to be done.”
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THE
LIGHT
I
n all her years conducting research, Narine Sarvazyan,
Ph.D., professor of pharmacology and physiology at the
George Washington University School of Medicine and
Health Sciences (SMHS), has had several ideas, but one
— a cardiac imaging catheter — is the closest she’s come to
traversing the information chasm between bench and bedside.
“There are still many, many hoops to jump through, but
we’re at least approaching [a clinical device],” she says. “It
doesn’t really happen very often in basic science research.
Usually we think, ‘Well, this might help sometime in the future
because we are providing basic knowledge of how things work.’
In this case, I am cautiously optimistic, let’s put it that way.”

Seeing the Invisible

Sarvazyan’s journey began with Marco Mercader, M.D.,
director of electrophysiology research and associate professor
of medicine at SMHS, and Matthew Kay, P.E., D.Sc., an
associate professor of biomedical engineering at the GW
School of Engineering and Applied Science (SEAS), when the
three began experimenting with NADH (a reduced form of
nicotinamide adenine dinucleotide) fluorescence imaging on
the surface of ischemic animal hearts. “If you illuminate tissue
with ultraviolet light, there’s a fluorescence that comes out, and
it can be picked up and detected in the laboratory,” explains
Mercader. “So Narine and I started experimenting with what
would happen if you did ablation of the cardiac tissue to the
fluorescence provided by NADH.”
Cardiac ablation, a procedure that burns or freezes
heart tissue in an effort to correct arrhythmia, such as atrial
fibrillation, comes with its own special set of complexities.
Right now, Sarvazyan says, surgeons perform ablation without
being able to see what happens to the tissue, which accounts for
the current success rate of the procedure: Typically, 60 percent
of patients see their arrthymia corrected, and 40 percent return
to the hospital for an additional procedure. Out of that number,
10 to 15 percent return one more time.
“There are different means to ablate abnormal sources
of electrical activity, but today a surgeon does not really have
the means to say, ‘OK, I destroyed the tissue,’ because this
procedure is essentially done in a blind fashion,” Sarvazyan
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BY CAROLINE TRENT-GURBUZ

WITHIN
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Sarvazyan and her team also
discovered that the intensity of the
assigned color was proportional to the
depth of the affected tissue. “Our data
suggest that when one plots the intensity
of the lesion component revealed by
hyperspectral imaging, it predicts how
deep the lesion is,” she says. “That’s
what is known as the holy grail of atrial
fibrillation treatment.”
In addition to the imaging fibers,
the catheter includes an illumination
fiber. “We need to minimize all parts
of the catheter for it to fit inside a vein,”
Sarvazyan explains. “So from a technical
perspective, our main challenge is to get
enough light to the tissue to illuminate
it, as well as to get enough light back so
we can actually spread it into individual
wavelengths to do hyperspectral image
analysis.” The team’s solution for the
current catheter was to envelop the
illumination fiber with a pear-shaped
saline balloon that acts as a kind of lens,
moving blood away from the fibers while
lighting the way forward.
says. “There are no direct imaging tools to visualize the
ablation process.”
That’s where Sarvayzan’s team comes into play. The
team’s goal was to develop a new generation of cardiac imaging
catheters that could detect changes in tissue autofluorescence
caused by ablation. The current version of their catheter,
designed to thread into a patient’s vein and up to the heart, has
17,000 imaging fibers, each capable of picking up a fluorescent
signal from the tissue and relaying it to a camera. She compares
it to a butterfly eye, capable of using multiple receptors to
receive light signals.
In order to see ablation lesions inside the heart, however,
it’s not enough to have a small and flexible imaging fiber
bundle, Sarvazyan says. Surgeons have to be able to detect
damaged tissue beneath thick layers of collagen covering
the inner surface of atrial tissue. “The contrast is very, very
small,” she says. “So, to be able to reveal damaged tissue, we use
technology called ‘hyperspectral imaging.’ ”
Hyperspectral imaging, which has long been used in
agriculture and astronomy, is rapidly gaining popularity for
clinical applications. With the help of a computer, Sarvazyan
explains, it can distinguish individual pixels based on the
small spectral differences between them, creating a color map
showing ablated tissue and viable gaps still needing ablation.
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Seeking Partnership

While progress ticked along at the bench, Sarvazyan and
Mercader, wanting to move their catheter to the translation
phase, needed to find financial support. The first phase of the
project, Mercader says, was funded by GW and SMHS clinical
partner GW Medical Faculty Associates. Then, he adds, came
the question: “How are we going to get other people interested
in this?”
They started by drawing attention to their work. In
2011, the team submitted their idea to the GW Open House
and Innovation Competition. They then filed a patent, with
Mercader leading the way to find an investor, which he did:
venture capital firm Allied Minds. Together, Allied Minds
and GW formed a joint company, LuxCath, LLC, which then
sponsored a small business, Nocturnal Product Development,
LLC. The latter company, essential to the catheter’s
development, is an engineering firm specializing in biomedical
device design and manufacturing. More recently, the team
welcomed Murray Loew, Ph.D., professor of biomedical
engineering at SEAS, to help with additional image analysis
and processing of algorithms.
Next, with Nocturnal Product Development as their small
business partner, Sarvazyan’s team applied for and received a
$200,000 National Institutes of Health (NIH) Phase I Small

Business Technology Transfer (STTR) Program award in 2014.
“Phase I allows one to have the initial funds to prove that the
main concept works,” Sarvazyan explains.
The pace of progress slowed when it came to the larger
STTR Phase II award. The NIH, Sarvazyan says, is keen on
translating whatever researchers find in the lab to the real
world, and Phase II of the grant includes elements critical
to that goal, such as a marketing plan. “That was certainly
uncharted territory for me,” she says, “but we got it done with
help from a marketing firm and our business partners.” In April
2015, she submitted the paperwork for the grant, and by July,
the team had received a high score on the proposal, successfully
checking off each of the criteria.
The NIH, she says, typically awards a Phase II STTR
grant two or three times a year. Given her past experience in
the grant process and the top marks for her project, Sarvazyan
thought the award was a given. At first, “obviously, everyone
was ecstatic,” she recalls. “When you get a score like this, you
think that you are definitely going to receive the money. But
in the fall of 2015, the NIH changed its rules by adding yet
another layer of selection for this specific type of grant, which
gave us a lot of anxiety.” Sarvazyan was now caught in limbo.
“The hardest part was that once you get this score, everyone
you call — your chair, your students — they all assume you get
the money,” she says. “But then for a year, we were still awaiting
the NIH final decision, while trying to keep our team and
spirits together. ”

Finally, in August 2016, Sarvazyan received the news.
“Luckily for us, the decision was in our favor.”
The two-year grant, totaling $2.27 million, is split between
GW and Nocturnal Product Development, with Sarvazyan
as the primary investigator. Since the award, the project has
moved one step closer to the bedside: On Jan. 31, 2017, the team
conducted a large animal study using the first iteration of the
hyperspectral imaging catheter. Mercader also traveled to
Europe to test an earlier, simpler version of the catheter to get
feedback on its functionality.
“We’re so very proud that the catheter made it into an
actual catheter; it comes in a box, has a name and a serial
number, and it was actually [used] for the first time this year,”
Mercader says. The team went to Prague to do first-round
testing with both U.S. and local electrophysiologists.
For now, the team is implementing the many tasks
outlined in Phase II and preparing for Phase III, which
requires a matching investment from a venture capital firm or
angel investor to qualify for NIH support. In the meantime,
however, Sarvazyan and her team can already lay claim to a
major milestone. They are the first at SMHS to receive an
STTR Phase II award.
“We believe and hope that this powerful new technology
will finally help cardiac surgeons and electrophysiologists to
see what was once invisible,” she says.
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O B S E R VAT I O N :

On Autism

Opening New Doors on Autism
and Neurodevelopmental Disorders
BY STEVE GOLDSTEIN

As one of the world’s pre-eminent autism researchers,
Kevin Pelphrey, Ph.D., has built a reputation that
can open the doors to virtually any medical research
institution — and the institution would consider itself
fortunate to have him. But Pelphrey chose The George
Washington University (GW).
Why? Because his ambitions as director of the new Autism
and Neurodevelopmental Disorders Institute (ANDI) extend
beyond investigation, to influence.
“We’re interested in influencing policy decisions,”
says Pelphrey, citing one of the three chief priorities of the
institute, which embraces research and clinical care and will
be housed primarily in a state-of-the-art clinical center at
GW’s Virginia Science and Technology Campus in Ashburn.
In addition to his role as director, Pelphrey, a boyish-looking
43-year-old, is the inaugural Carbonell Family Professor in
Autism and Neurodevelopmental Disorders, and professor of
pharmacology and physiology at the GW School of Medicine
and Health Sciences. Through ANDI, Pelphrey is creating
a one-stop resource for families affected by autism in the
Washington, D.C., area and beyond by connecting faculty
members at six GW colleges with clinical partners GW
Hospital, Children’s National Health System, and the GW
Medical Faculty Associates.
As part of the network, Pelphrey will be joined by Ashley
Darcy-Mahoney, Ph.D., assistant professor of nursing at the
GW School of Nursing and a neonatal nurse practitioner,
who will serve as ANDI’s director of infant research. “She
was a terrific hire that I didn’t have to do,” says Pelphrey, who
celebrated his first anniversary at GW on April 1.

A Firm Foundation

ANDI received $12 million in initial funding for research.
Pelphrey cites the recruitment efforts of GW Vice President
for Research Leo Chalupa, Ph.D., as very persuasive, and is also
grateful for the commitment of GW Board of Trustees Chair
Nelson Carbonell, B.S. ’85, who gave $2.5 million to establish
the endowed professorship Pelphrey holds. Carbonell’s son,
Dylan, was diagnosed with autism as a 2-year-old.
Autism is relatively common, affecting an estimated
one in every 68 children in the United States, yet it is widely
misunderstood. So broad are its manifestations that it is
described as a “spectrum” disorder. Autism may be experienced
as the gaze unmet, the outstretched hand unshaken, the
conversation turned riddle. The disorder is a mental prison of
sorts, in which the “inmate” has difficulty communicating and
forming relationships with other people and in using language
and abstract concepts.

Close Ties and Choice Connections

Pelphrey has two major priorities for the institute. The first,
he explains, is building a comprehensive clinical and research
infrastructure. If parents have concerns about their child’s
development and they start thinking about a place to go,
Pelphrey wants them to think of GW and ANDI. “We need to
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be able to comprehensively evaluate the patient, provide advice
and discuss possible neurodevelopmental treatments, and have
the research that will explain the kinds of therapies that will
work, and ones that may not,” he says.
The second priority is for the institute to serve as a
national model for treatment in post-adolescence. Therapies
for autism spectrum disorder cannot be narrowly focused
on children from infancy to 3 years old. The adult transition,
especially during the teenage years, is also an important
period in brain development. “The brain is reorganizing,” says
Pelphrey, and it presents opportunities to intervene. He adds
that there’s “a wave of young adults with autism coming in the
next 10 years.”
Pelphrey has been studying brain development for
16 years, beginning as a postdoctoral researcher at Duke
University. Practical considerations — “it was hard to build
academic tenure,” he notes — caused him to jump off that
track for a while. Personal issues drove him back, intensively.
“My daughter, Frances, was diagnosed with autism when she
was a little over 3 years old,” he explains. “We noticed general
developmental delays and a slowness in developing language.
But she was very social with people and that delayed the
diagnosis for a bit.”
Frances, now 13, provided passion and a new focus for
Pelphrey. “This delay in diagnosing girls compared with boys
got me very interested in studying girls with autism,” he says.
Why are girls such as Frances underdiagnosed? According to
Pelphrey, boys are more susceptible to neurodevelopmental
disorders than girls. Moreover, there’s a kind of “masking”
related to girls in that they tend to appear more social than
boys. “Thus you have a significant number of girls with
problems, but they are not rising to the diagnosis level to
get the attention they need,” he says. Pelphrey is the leader
of an NIH-funded, $15-million multi-site project to study a
large sample of girls with autism with a focus on genes, brain
function, and behavior throughout childhood and adolescence.
Darcy-Mahoney’s work addresses another underresearched subject: the connection between autism and
prematurity, and particularly how this is represented
among African Americans, who have a much higher rate of
preterm babies. “African American children with autism
are significantly under-represented and significantly
underdiagnosed — and probably diagnosed in a less timely
fashion,” she says. Darcy-Mahoney, who arrived from Emory
University in July, says the School of Nursing also has an
Ashburn campus, “so we hope to cross-train in the area of
neurodevelopmental pediatrics.”

Broader Perspectives

When Pelphrey first entered the field in 2001, autism was
viewed very narrowly and “virtually nothing had been done
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on sex differences.” He began exploring the theory that it
was a disorder of early brain development that changes over
time. Now, studies have concluded that autism “is a disorder
of mid-fetal brain development that begins in utero,” Pelphrey
explains. Additionally, research has revealed reliable brain
“signatures” of the disorder, which allows it to be traced
over time. “This has gotten much more complicated than we
ever dreamed of,” he adds, “and we’re talking about a whole
collection of disorders.”
ANDI will also provide cutting-edge advice on
treatments, including behavioral interventions and
pharmacological therapies. Pelphrey says the institute will
explore why behavioral interventions are unsuccessful with
some children and will employ drug interventions to increase
responsiveness to behavioral therapies. Cognitive behavioral
therapy will be studied as a method of treatment for older
children and teenagers, who sometimes exhibit aggressiveness
and social anxiety.
Pelphrey’s familiarity with the Washington, D.C., region
— his wife’s family owns an oyster farm in Virginia Beach,
Virginia — helped convince him that ANDI could have a
wider impact. “We will be able to get attention through direct
contact with policy-makers,” says Pelphrey, who is on the
federal Interagency Autism Coordinating Committee. “That
prospect is very exciting.”
“On Autism” is the first installment of a new online, long-form nonfiction series,
OBSERVATIONS, covering several of the George Washington University School
of Medicine and Health Sciences areas of academic excellence. Look for the next
installment of “On Autism” at observations.smhs.gwu.edu.

Altruistic Spirit
SMHS donors provide “gift of life” to
kidney patients in December 2016
BY CAROLINE TRENT-GURBUZ

A

t the George Washington University (GW)
Transplant Institute in January 2017, Jose Reyes
and Andrew Lewis stood in the waiting room. The
two — each of whom had received a kidney from
an anonymous donor in mid-December 2016 — watched as the
door to the exam rooms opened.
“Meet your donor!” said J. Keith Melancon, M.D., chief
of the Division of Transplant Surgery, director of the GW
Transplant Institute at GW Hospital, medical director of the
GW Ron and Joy Paul Kidney Center, and professor of surgery
at the GW School of Medicine and Health Sciences (SMHS).
Lewis stepped back, visibly moved and struggling to form
words when Jacob Lambdin, a third-year medical student at
SMHS, approached.
“I’m speechless, but at the same time, I have so much I
want to say,” Lewis said. “I am so grateful.”
Lambdin, who plans to pursue surgery, explained his

decision to give his kidney to Lewis simply: “Whenever people
ask why I decided to donate, I tell them ‘It’s a good thing to do,
why not?’ ”
Reyes, meanwhile, didn’t believe who his donor was;
he’d been convinced it was a man. Instead, Sarah Miknis,
photographer and production assistant with Biomedical
Communications at SMHS, walked out.
“You?” Reyes asked, as he enveloped Miknis in a hug.
Like Lambdin, Miknis felt compelled to donate. She’d
been on a bone marrow list for years, but never got the call for
a match. In the meantime, as an SMHS photographer, Miknis
had covered many kidney screenings and health events, and
decided that giving her spare organ to someone in need was the
right thing to do.
“If I’m healthy and I can [help] somebody, I want to do it,”
she said. “I have two kidneys, but I only need one.”
Donating, she added, wasn’t as hard a process as she’d
anticipated — she had multiple screenings and was given ample
time to consider her decision — and by winter, she was ready.
Both she and Lambdin donated within a day of each other,
effectively providing Lewis and Reyes with what Melancon
termed “the gift of life.”
“With everything that’s going on in the world, the
one thing I get asked all of the time is ‘why?’ ” Melancon
continued. “All I can say is, ‘I don’t know, but it gives me faith
in humanity.’ [When you donate,] you’re not giving a kidney.
You’re saving a life.”
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TO PHARMA
BY KATHERINE DVORAK | PHOTOGRAPH BY JAMES PRISCHING
straight line might be the shortest route between
two points, but it’s not always the most desirable
course. For J. Carl Craft, M.D. ’72, a more direct
path might have led him far afield from his ultimate
career, and the world of pharmaceutical research would have
been far poorer as a result.
In high school, Craft was groomed for Stanford
University’s nuclear physics program; the father of a close
childhood friend was a researcher building the university’s
linear accelerator, and together, Craft and his friend were
regular visitors to campus, eagerly exploring the accelerator
and the computer equipment. As high school graduation
approached, however, Craft determined that nuclear physics
was not his path.
His next twist came during medical school. Initially,
Craft considered studying psychiatry, but soon decided you
“had to be crazy to do psychiatry,” though, he adds, “being
a nuclear physicist was even crazier.” By the time he left
for George Washington University’s (GW) Foggy Bottom
campus, he had his sights set on pediatrics — but his path had
one more kink in store.
The summer before his third year of medical school, Craft
took a summer job with Hazleton Laboratories in Virginia,
working on a project gathering data on Cromolyn sodium, an
asthma medication. “I collected and evaluated the data, then
wrote the package insert [the description and classification,
regulatory specifications, and drug interaction materials] for
the drug,” he says. The total new drug application filing was six
copies of 92 volumes.
That experience foreshadowed Craft’s future in
pharmaceuticals, but years would pass before he found himself
working in the industry.
Craft graduated from GW a married man in 1972, and
he and his wife, Susan, moved to Wisconsin for his pediatrics
residency at Milwaukee Children’s Hospital. It was the Vietnam
Era when he completed residency, he recalls, and those who
guaranteed two years of military service could select the branch
they would join. Craft joined the Navy. “That allowed me to
finish my training,” he explains. “I entered as a pediatrician
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[serving in Guam as lieutenant
commander and chief of pediatrics at the
U.S. Naval Regional Medical Center],
which was lucky since the war ended
and 100,000 women and children were
temporarily housed on Guam before
being moved to the mainland.”
Following military service, Craft
started a pediatric infectious disease
fellowship at the University of Texas
Southwestern in Dallas under the
guidance of George McCracken, M.D.,
and John Nelson, M.D., founders of The
Pediatric Infectious Diseases Journal.
He later joinedthe faculty at Tulane
University in New Orleans, where he
treated patients with infectious diseases,
taught students, residents, and fellows,
and was an investigator in clinical trials
for pediatric antimicrobial drugs.
Despite his steady progression in
medicine, Craft felt himself drawn to
clinical drug research — specifically
to Abbott Laboratories, where he
developed the antibiotic clarithromycin, the first billion-dollar
drug. When the pharmaceutical giant decided to move out of
anti-infective drug development, however, Craft retired, but
kept an eye open for the next turn of his career path.
That turn came up quickly in the form of Medicine for
Malaria Venture (MMV), a new, nonprofit foundation funded
by The Bill and Melinda Gates Foundation (BMGF) and
others, designed to work on malaria drugs. At MMV, Craft,
who served as chief scientific officer, developed the largest antimalaria drug portfolio to date. MMV has continued to work
to eliminate malaria with new medications, created with the
stipulation that they cost no more than $1 per treatment.
Both during and after his tenure at MMV, Craft served as
a scientific adviser to Drugs for Neglected Disease Initiative
in Geneva, a nonprofit drug research and development

organization that works on new treatments for neglected
diseases, such as leishmaniasis, Chagas disease, and parasitic
infections. He also served as a scientific adviser to an
ANACOR Pharmaceutical and BMGF project to develop new
drugs for tuberculosis and macrofilarial diseases. Rounding out
his role as a scientific adviser, Craft, who maintained the role of
chief medical officer as well, helped start a new drug company,
CEMPRA Pharmaceutical, which is developing two antiinfective agents for serious infections.
More recently, Craft launched Aquarius Biotechnologies
Inc. The company, he says, has developed new delivery
technology for large-molecule drugs that cannot be
absorbed from the gastrointestinal (GI) tract. When given
intravenously amphotericin B can decrease nephrotoxicity.
Only through nanotechnology, or cochleates, can molecules

like amphotericin B be taken orally. The cochleates, he
explains, are absorbed across the GI tract, actively taken up
by macrophages within the blood stream, and delivered to the
site of infection through the patient’s lymphatics. As a result,
high levels of the drug do not appear in the blood stream,
which could decrease kidney damage.
This unique drug delivery technology, he adds, can
formulate and stabilize a variety of molecules, including
pharmaceutical drugs; insulin and vaccines; peptides; DNA
plasmids, or gene therapy; and siRNAs.
Craft’s career may have drawn him away from his
high school plan of studying nuclear science, but the path
he followed led to an illustrious career of discoveries in an
innovative medical field.
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Francis L. Delmonico, M.D. ’71
Championing an End to
Organ Trafficking

O

n an evening last summer, Francis L. Delmonico,
M.D. ’71, and his wife, Janice, attended a
fundraising dinner at the tony Beacon Hill
residence of Martin Walsh, the mayor of
Boston. With Mayor Walsh and the Delmonicos that night
was Monsignor Marcelo Sánchez Sorondo, chancellor of the
Pontifical Academy of Sciences. Seated at their table was
Jack Connors, CEO of the Board of Trustees for the Partners
Complex of the Massachusetts General and Brigham and
Women’s Hospitals. Looking out at the tables surrounding
them, the Delmonicos saw a room packed to capacity with
Boston’s social elite.
“We’re looking at each other, thinking ‘what are we doing
at this table?’ ” chuckles the genial, self-effacing surgeon. Of
course, the couple knew exactly why they were there — to raise
money in support of the Pontifical Academy of Sciences and its
mission to fight the global trade in human organs — but the real
question was how did they get there.
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BY THOMAS KOHOUT

Less than a year earlier, on Feb. 15, 2016, Pope Francis
named Delmonico to the Pontifical Academy of Sciences,
a centuries-old scientific community founded to “honor
pure science wherever it may be found, ensure its freedom,
and encourage research for the progress of science.” The
lifetime appointment puts Delmonico among 80 of the
world’s most eminent scientists and academicians, those
acknowledged as much for their “moral personality” as their
intellectual accomplishments.
“I was not accepted [to medical school at George
Washington University] the first time I tried,” recalls
Delmonico, marveling at the distance his medical career has
covered. “The dean of admissions at that time, Paul Calabrisi,
Ph.D., told me ‘you’re not going to get in this year. You have to go
back and retake the medical admission test again. If you improve
your score, and then you come back to me, you’ll do well here.’ ”
The reassurance, Delmonico says, changed his life. “It
gave me the confidence to come back — the notion that if I

worked hard, I’d have a chance. I loved GW. It was a great
place to go to school.”
Since that early setback, Delmonico has built
a breathtaking resume that features, among other
accomplishments: professor of surgery and Emeritus Director
of Renal Transplantation at Harvard Medical School and
Massachusetts General Hospital; recipient of the National
Kidney Foundation’s David M. Hume Lifetime Achievement
Award; adviser to the World Health Organization in matters
of organ donation and transplantation since 2006; and
current chief medical officer of New England Donor Services,
which oversees all deceased organ and tissue donation for
New England.
With his appointment to the Pontifical Academy — which
features among its membership scores of Nobel laureates, such
as Werner Arber, Ph.D., president of the Pontifical Academy;
David Baltimore, Ph.D.; and Ada E. Yonath, Ph.D., as well as
noted physicist Stephen Hawking, Ph.D. — Delmonico has
ascended to some rarified heights for a middle-class kid from
Brooklyn, N.Y.
Selection to the academy, unexpected as it may have been
to Delmonico, makes perfect sense on closer inspection. By all
accounts, the agenda laid out by Pope Francis is progressive;
topics such as refugees, climate change, immigration, and the
marginalized are regularly featured in his writings and addresses.
Within discussion of the marginalized, explains Delmonico, you
find human slavery, and that is where you find organ trafficking.
The social media-savvy pontiff made his feelings on the subject
unequivocal in an August 2016 tweet: “New forms of slavery such
as human and organ trafficking, forced labor, and prostitution
are true crimes against humanity.”
Delmonico, who was in Vatican City leading a two-day
summit on organ trafficking and transplant tourism in
February 2017, is well-versed on the subject and its associated
crimes of exploitation, coercion, and kidnapping. The market
for human organs is big, he says, estimating that organ sales are
involved in as many as 13,000 transplants each year, adding,
“we are trying to report instances of organ trafficking to the
appropriate authorities.”
In 2011, Global Financial Integrity, a nonprofit research
and advisory organization that analyzes international financial
systems and illicit revenue, reported that the illegal organ trade
had grown to be a $1.2 billion industry. The World Health
Organization also reports that all-inclusive kidney transplant
packages can be had, for those who can afford them, for prices
ranging from $70,000 to $160,000.
In the United States, a vast health care network has
evolved to facilitate transplants through both deceased and
living donations. Health insurance helps meet the high costs
of surgery and a lifetime of anti-rejection medication, enabling
the middle class and even the poor to receive lifesaving organ

transplants. That system, however, is not universal.
Wherever the rule of law has broken down, Delmonico
says, you’ll have people ready to prey upon the desperate, and
there you’ll find organ trafficking. In these destabilized regions
of the world, such as Afghanistan, “people are taken from
their villages, thinking they’re going to have a job when they
reach their destination. [Instead] they’re taken to some place,
confined,” he says. “They’re held, kidnapped. There is no job.
And they’re told, ‘You’ll sell your kidney or we’ll harm you by
turning you over to the Taliban.’ That’s human slavery.”
At the end of the two-day summit, participants issued
a statement, concluding that “organ trafficking and human
trafficking for the purpose of organ removal are true crimes
against humanity [that] need to be recognized as such by all
religious, political and social leaders, and by national and
international legislation … we, the undersigned participants
of the Pontifical Academy of Sciences Summit on Organ
Trafficking and Transplant Tourism, resolve to combat these
crimes against humanity through comprehensive efforts that
involve all stakeholders around the world.”
What would the best outcome for the summit look like?
Ideally, Delmonico says, engaging governments, using the
stature of the Pontifical Academy, to take action on organ
trafficking. Realistically, he understands the situation may
not change unless the academy has the support of a larger
community of media, governments, and medical professionals.
“The best way to put it,” he says, is “the summit is leading
to action items, an action agenda to specific locations to
make change.”
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BY KATHERINE DVORAK
frican trypanosomes are masters of disguise.
Delivered through bites from the tsetse fly, once
inside a host these parasites quickly disguise their
appearance in a process called antigenic variation, all
to avoid detection — and no parasite does it better.
But how do organisms like trypanosomes, in their effort to
colonize an inhospitable environment, regulate their genes and
fool an animal that doesn’t want them there? That is the crux of
Galadriel Hovel-Miner’s research.
Hovel-Miner, Ph.D., assistant professor of microbiology,
immunology, and tropical medicine, opened her lab at the
George Washington University (GW) School of Medicine
and Health Sciences (SMHS) in December 2015. Her goal was
to uncover the genetics behind a parasite’s ability to infect its
host, and attribute those genes to their function. Doing so
could expose gaps in the parasite’s defenses, leading to future
targeted therapeutics. When it comes to trypanosomes, HovelMiner notes, that goal is a little daunting; so far, more than 60
percent of the genome remains a mystery.
Trypanosomes thrive in sub-Saharan Africa and spread
African sleeping sickness. Ultimately, the trypanosomes’
genetic shroud enables them to slip across the blood-brain
barrier undetected, where they enter the central nervous
system. In the late stages of the disease, infected humans and
other animals lose their sleep pattern; they sleep all day and are
awake all night. The sleeping sickness itself, explains HovelMiner, is the end stage of the disease, caused by brain damage.
The illness not only affects thousands of people living in
sub-Saharan Africa, but also lays waste to livestock, financially
devastating already poverty-stricken regions.
In addition to the human suffering the parasites create,
Hovel-Miner says there are two other reasons her lab is
interested in trypanosomes: They are the textbook parasite
for antigenic variation, and their method of disguise is unique,
accomplished by shuffling genes around in the genome.
That gene shuffling is perhaps one of the most intriguing
aspects of her work, says Hovel-Miner. Trypanosomes, to
perform antigenic variation, have only one gene expressed,
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or turned on, at a time. Unlike other
pathogens that may have just a few
antigenic genes at their disposal,
trypanosomes have more than 2,000
cloaks with which to shroud their
identity.
“How do you go from one [gene] to
one of the other 2,000? That’s really the
question,” Hovel-Miner says.
Normally, in a mammalian genome,
moving the genes around would be very
dangerous, she adds. “It’s something you
pretty much want to do only when you’re
an egg and a sperm coming together
to make a new person or animal, a
genetically unique one. A lot of times
moving things around in the genome
… can result in genetic disorders and
cancers. These are the kinds of actions
that cause genetic damage, which can
result in disease,” she explains.
Understanding how trypanosomes
efficiently move a silent gene from
one position in the genome to become
active in another position without
incurring extra damage would open
doors to an even better grasp not only of
trypanosomes’ use of antigenic variation,
but also of the genetics associated with
human disease overall, Hovel-Miner
says.
The lab is also investigating the drug
resistance of trypanosomes. Knowing
which genes lead to drug resistance could
help researchers identify new pathways
associated with that resistance.
Although currently many stages
away from the long-term goal of having a

testable drug, Hovel-Miner hopes to find a better treatment for
the disease that would inhibit the growth of the trypanosome.
“There are drugs, but there are only a limited number
of them, and while they’re fairly effective, they’re also highly
toxic. There aren’t very many of them, so drug resistance is a
threat, and any resistance could be a real problem,” she says.
To learn more about the parasites’ genes, Hovel-Miner
employs a genetic tool known as a “whole genome gain-offunction library.”
“This is a library of every gene in the trypanosome genome
that we can turn on when we want to. So we put all the genes
that we have under our control into a population of cells, we

treat the cells with a condition, and then we see what genes are
present post-treatment,” she explains.
Lab members are also modifying genes in the organism,
as well as looking at how the genes of the trypanosome move
through the genome.
“We know that [gene shuffling] begins with a DNA break,
so we can look at how DNA breaks form and, following the
formation of a DNA break, [examine] how things shuffle,”
Hovel-Miner adds. “It now looks like some of this is associated
with cell division and cell division defects. We’re starting to
[look closely at] how the cells divide, because our data suggest
that it’s connected.”
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obbie Russell walked onto the soccer pitch to the
thunderous sound of 80,000 voices singing: “Die
meister [the masterful], die besten [the best], les
grandes equipes [the great teams], the champions.”
That was 13 years ago, and Russell was a right back playing
for Norwegian professional soccer club Rosenborg BK. It was
one of his first matches in the Champions League, an elite
European soccer tournament.
“To this day, hearing that song gives me goosebumps,” he says.
Now a third-year M.D. student at the George Washington
University (GW) School of Medicine and Health Sciences,
Russell has come a long way from the soccer field. But every
step he’s taken — from playing for clubs in Norway, Denmark,
Salt Lake City, and Washington, D.C. — has led him to his
dream of practicing medicine.
Russell first came to GW looking to study orthopedic
surgery; it’s what impressed him from watching doctors tend to
his teammates. Once at GW, his interests shifted to emergency
medicine, partly because of the pace and the day-to-day
challenges. “I love the fact that coming into work, I don’t know
what I’m going to see. It’s very exciting; it’s very scary,” he says.
So far Russell is making the most of his time at GW. He serves
as vice president of the Student National Medical Association, as
co-president of the GW Emergency Medicine Interest Group, and
as a member of the D.C. Department of Health’s Medical Reserve
Corps, managed by the GW Medical Faculty Associates, a medical
response and disaster team.
Russell discovered his aptitude for soccer during high
school. His mother worked three jobs to help support the
family, but affording college seemed out of reach. Russell’s
prowess as a player paid off, however, and Duke University
offered him an athletic scholarship.
Despite his success as an athlete, Russell says he was always
drawn to science.
“I started off college as pre-med, but then I walked into my first
calculus course and bombed it. So I thought, ‘I can’t threaten my
GPA, I’ll just do the general athlete program and go from there.’ ”
The “from there” turned into a 14-year professional soccer
career that Russell greatly cherishes.
When Russell was traded to D.C. United in 2011,
“everything started to align.” He was finally living in the same
city as his wife, Tiana, who worked in D.C. while he played for
Real Salt Lake. After retiring from soccer, Russell completed a
post-baccalaureate premedical program, and was accepted as an
M.D. student at GW.
Russell now puts the focus and drive he showed on game
day into his work at GW, and spends his free time with Tiana
and their two sons, Leo and Lucas.
“Everything that’s ever happened to me, good or bad, has
taught me something. And if I don’t apply it now, I’m doing
those experiences a disservice,” he says. “I hope to bring all of
those experiences to my work in medicine.”

R
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From Pitch
to Patients
BY KATHERINE DVORAK

Path
through
Paraguay
BY KATHERINE DVORAK

A

s a child growing up in a small village in western
Paraguay called Santa Rosa, Cheralyn Hendrix, M.D.,
recalls standing by her father’s side as he sewed up a
gash from an ax wound on the palm of a 12-year-old
boy’s hand, and spending mornings and afternoons with her
mother as she provided aid to the community of 150 people.
“That’s really how my interest in medicine began, being
this right-hand person in this tiny little clinic that my mom
started,” says Hendrix, a surgery resident at the George
Washington University (GW) School of Medicine and Health
Sciences (SMHS).
Hendrix’s parents worked as missionaries in Paraguay
for 25 years. Her mother started a vaccination program in the
village and educated its members about medication adherence;
her father helped with wound care and suturing.
Her parents’ dedication to their patients and the
community is at the core of what drives Hendrix in her work at
GW. “They’re so passionate about it, and I want my life to have
that kind of passion,” she explains.
Hendrix lived in Paraguay until she was 18, at which point
she immigrated to the United States to pursue a career in

medicine. She has moved all over the country with her husband,
who serves in the U.S. Air Force, while raising four children,
the youngest of whom is 9.
“They’re really why I can do what I do,” she says of her
family. “I feel like I have an added measure of stability, because
I have this incredible support structure at home. They’re really
proud of me, and I can’t even tell you what that does for me [in
terms of] spurring me on.”
Hendrix earned her medical degree from the University of
Arizona at Tucson, and now, in her second year of residency at
GW, is pursuing trauma surgery. She made that career decision
in part because of the hands-on time she spent helping her
parents care for their patients in Paraguay.
“I never felt as invigorated or as inspired as I did when I
was working on surgical rotation. That was the one thing I
found in medical school, that it didn’t matter how many hours I
worked, I was thrilled to be working with my hands,” she says.
“I’d rather be tired and fascinated than working fewer hours
and feeling like I’m not doing what I most enjoy. I love never
knowing what’s coming through the door.”
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BY KATHERINE DVORAK

ith the support of grants from the National
Institutes of Health (NIH), Pedro A. José, M.D.,
Ph.D., professor of medicine in the Division of
Renal Diseases and Hypertension and professor
of pharmacology and physiology at the George Washington
University (GW) School of Medicine and Health Sciences, is
exploring how the body disposes of salt. Salt sensitivity is an
underdiagnosed condition of hypertension, and insight into the
process may lead to more personalized treatments for patients.
Sodium channels in the stomach sense salt levels in the
food, José says, and those cells secrete the hormone gastrin,
to alert the kidneys that they need to make more dopamine;
gastrin and dopamine team up to rid the body of the excess salt.
For some people, taking in too much salt will cause blood
pressure (BP) to rise, but about 15 percent of people see higher
BP if they take in too little salt, José says. The trouble, he adds,
is that there’s no way to know who falls under which category.
Discerning how the stomach senses salt levels, and
the channel of communication through which gastrin tells
the kidneys to make more dopamine, may lead to a better
understanding of salt sensitivity, says José.
To investigate how the communication occurs, researchers
put catheters into mice blood vessels that go into the stomach
and the duodenum. Next, they added short interfering RNA
(siRNA) to genetically disrupt the gene, he explains. “So, if
you put in the siRNA … [and] direct that against the sodium
channel, you’ll only be disrupting the sodium channel in the
stomach and duodenum.”
By limiting the disruptions just to sodium channels in the
stomach, the technique prevents the body from making excess
hormones in other areas that can be harmful, José adds.
The current NIH grants through which José is conducting
his research include “Renal Dopamine-1 Receptor Defect in
Hypertension,” a recently renewed grant for a total of more
than $1.7 million, as well as a grant totaling more than $3.7
million awarded to GW via the University of Virginia, for
which José is a subcontractor, “Dopamine and Angiotensin
Receptor Interactions in Genetic Hypertension.”
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In addition to his research at GW, José is wrapping up
a yearlong stint as the chair of NIH’s Hypertension and
Microcirculation Study Section. The study sections review and
approve grants admitted for funding.
“It’s important that one [reviews the grants] to ensure the
review process is fair, and that the review process really comes
up with the best proposals to be funded by our government,”
he says.
It’s not his first rodeo with NIH study groups. José
previously chaired the same study section, which was
previously called the Cardiovascular and Renal Study Section
B, from 1996 to 1998.

FACULTY NEWS
Leading Education at
GW Cancer Center
Robert Siegel, M.D. ’77, has been selected
to serve as the George Washington
University (GW) Cancer Center’s associate center director for education and
training. Siegel joined the GW School
of Medicine and Health Sciences in
1982 as a professor of medicine.
His research interests focus on
refining therapies for breast and head/
neck cancers. He has supervised the
medical school’s second-year program
in hematology since the fall of 1982,
and is the director of the GW Board
Review Course, the largest program of
its kind focusing on hematology and
oncology in the country.

A New Disorder
M. Chiara Manzini’s curiosity was piqued
when she met a set of new patients.
“The patients were very short, and
they had skeletal deficits,” explains
Manzini, Ph.D., an assistant professor
at the George Washington University
(GW) Institute for Neuroscience and
the Department of Pharmacology
and Physiology at the GW School of
Medicine and Health Sciences.
In the severe forms of congenital
muscular dystrophy she studies,
patients typically present with progressive muscle weakness as well as
intellectual disability and vision issues
such as cataracts. The additional
characteristics her patients displayed,
however — short stature and unique
skeletal features — were highly unusual.
Manzini collaborated with scientists from around the globe, and
they discovered that the removal of a
specific gene, INPP5K, resulted in the
muscle disruption, lens disruption, and
smaller brain that she had observed.
In other words, Manzini and her fellow
researchers had discovered a new type
of congenital muscular dystrophy.

The group has since published two
papers and is working to better understand how the INPP5K gene functions
in the muscle and the brain.
“The gene is very interesting, so
we’re definitely going to keep pursuing
it,” Manzini says. “Hopefully, it’s going
to be interesting to other people. From
a science standpoint, it’s a different
mechanism from what had been previously looked at in these disorders. It may
change the way we think about them.”

Crusading for Clinical Trials
Sitting in his office on the eighth floor
of the Science and Engineering Hall,
Mitchell Smith, M.D., Ph.D., associate
center director for clinical investigations at the George Washington
University (GW) Cancer Center, lays
out his vision for a center that pioneers
new treatments, rapidly delivers them
to patients, and engages with the
community it serves.
“It’s always been the goal to take
good care of patients, but now we want
to be on the cutting edge in terms of
research and providing access to new
drugs for patients,” he says.
In his role, Smith oversees all
cancer clinical trials. He sees the GW
Cancer Center becoming a hive of
activity, opening new trials at a fast clip,
while developing a strong focus on
in-house science.
“We have to streamline all the
paper and the regulations, make sure
we can be nimble in terms of someone
approaching us with an interesting
study we want to do. We want to open
those trials quickly, and we have to
demonstrate that we can [attract]
patients to them,” he says.
Smith also works to enhance trust
in the community to grow participation
in the trials the center runs. It’s the GW
Cancer Center’s job to reach out to
people living in underserved communities and educate those residents,
he adds.

GWMEDICINEHEALTH.COM

35

FACULTY NEWS
The Connection between
HIV and Cancer

Give Me Some Skin
An international survey on sun
exposure behaviors and skin cancer
detection found there are many imperfections and geographic inequalities in
prevention of skin cancer.
Information from the study,
published in the Journal of the
European Academy of Dermatology
& Venereology by researchers
from La Roche-Posay and the
George Washington University
(GW) Department of Dermatology,
could help inform future awareness
campaigns developed to address
the need to reduce the incidence of
skin cancer.
With nearly 20,000 participants
around the world, it was one of the
largest international studies of its
kind on consumer sun protection and
behaviors. Survey results indicated
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that 88 percent of respondents were
aware of the risks of developing skin
cancer when exposed to the sun
without protection. However, four in
10 respondents said they don’t think
to protect themselves from the sun
outside vacation.
“This is a global wake-up call,” says
Adam Friedman, M.D., senior author
for the study and associate professor
of dermatology at the GW School of
Medicine and Health Sciences. “There
are still a lot of gaps in people not only
actively monitoring for cancer, but
preventing it.”
According to the data, using
sunscreen and wearing sunglasses
were the most frequent preventive
measures. Education level, as well as
gender, influenced the degree of sun
protection: A higher level of education corresponded to a higher level of
sun protection.

With a $2.2 million National Cancer
Institute grant, Douglas Nixon, M.D.,
Ph.D., chair of the Department of
Microbiology, Immunology, and
Tropical Medicine and Walter G. Ross
Professor of Basic Science Research
at the George Washington University
(GW) School of Medicine and Health
Sciences (SMHS), alongside GW
collaborators, is examining how human
endogenous retroviruses (HERVs)
impact certain types of cancers.
HERVs are ancestral remnants of
past viruses that, passing from mother
to child, have been integrated into
DNA. Nixon’s research team, which has
published studies on the effect of HIV
infection on HERVs, has found there
may also be a link between HIV and
cancer.
“It appears that breast and
prostate cancer are found less
frequently in HIV-infected people than
in the general population,” Nixon says.
Nixon and his team hypothesized
that HERVs stimulate an immune
response, which surveils prostate
and breast cancer cells that could be
expressing the same HERVs. To test
this theory, Nixon, with Ph.D. rotation
student Matthew Bendall and Keith
Crandall, Ph.D., director of the GW
Computational Biology Institute at
the Milken Institute School of Public
Health at GW, developed “Telescope,”
a computational pathway program, to
determine which HERVs are expressed
in prostate, breast, and colon cancers,
in patients with and without HIV.
“This is really a brand new tool,
which we think will be incredibly
valuable to look for expression of these
endogenous retroviruses in a number
of different disease categories,
including in cancer,” Nixon says.

Patricia Berg Selected as
2016 AAAS Fellow
The American Association for the
Advancement of Science (AAAS)
named Patricia Berg, Ph.D., professor
of biochemistry and molecular
medicine at the George Washington
University School of Medicine and
Health Sciences, a fellow of the AAAS.
Berg was selected for her “important contributions to cancer research
with the discovery of BP1 protein, activated in 80 percent of breast cancers
and 70 percent of prostate cancers,”
according to the AAAS.
Berg also discovered that the presence of BP1 protein increases as breast
cancer progresses from normal tissue
to aggressive breast cancer. BP1 is
associated with increased cell growth,
resistance to drugs, and metastasis.
Moreover, BP1 protein can control
other genes, including several oncogenes known to cause breast cancer.
Her work has had a dramatic effect on
cancer research.

Streamlining a Solution
In March 2017, Raja Mazumder, Ph.D.,
associate professor of biochemistry
and molecular medicine at the George
Washington University School of
Medicine and Health Sciences, and
his team, including research associate Charles Hadley King, hosted a
public workshop for more than 300
participants at the National Institutes
of Health to get feedback on “biocompute objects.”

Biocompute objects, or records
with various data, such as validation kits, the associated metadata of
executable programs, and software
arguments and version information,
could allow for consistent and accurate
computation evaluations for studies
submitted to the FDA. To jump-start
the development process, however,
Mazumder’s team looked to the scientific community for input.
“The goal of the workshop was
to develop a community and engage
it in getting together to set these
standards. We did a good job accomplishing that,” King says, adding that
the “biggest win” from the workshop
was outside agencies agreeing to
develop biocompute objects on their
platforms.
The team is already planning
another workshop for 2018. “[The
March workshop] was well received,
and we’re [continuing] to work with the
community because things like this
require lots of collaboration and input,”
Mazumder says.

Between the Beats
A new technology, bioelectric impedance cardiography
(ZCG), which assesses blood flow in the chest to make
inferences about heart function, may lead to a new way to
identify heart problems. Now, with the help of the Health
Sciences Emerging Scholars grant, George Washington
University’s Josh Woolstenhulme, Ph.D., D.P.T., looks to
prove the effectiveness of that technology.
Woolstenhulme, an assistant professor in the
Department of Physical Therapy and Health Care Sciences,
explains that ZCG is different from traditional tools used
to assess heart function because it relies on the electrical
impedance of blood in the chest to determine how much
blood is pumped out of the heart during each beat.
The primary focus of Woolstenhulme’s project is to
validate the use of ZCG to assess diastolic function — the
part of the heart cycle when the heart is between beats and
filling with blood — while a patient is at rest, and while he or
she is exercising. Validating the technology for this purpose
might enable clinicians to better identify the presence of
diastolic dysfunction.
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FACULTY NEWS
Raising the Profile of
Team-Based Care
Karen Wright, Ph.D., P.A.-C., interim
chair and program director of the
Department of Physician Assistant (P.A.)
Studies at the George Washington
University School of Medicine and
Health Sciences, was recently selected
by the board of the American Academy
of Physician Assistants (AAPA) to serve
a two-year term as the medical liaison
between the AAPA and the National
Association of Medical Minority
Educators, Inc. (NAMME).
With a mission of transforming
health care through patient-centered,
team-based medical practice, said
Senior Director for Professional
Advocacy Ellen Rathfon, the AAPA puts
a high priority on building relationships
with other leading medical organizations. Wright, she added, was chosen to
represent AAPA, and the P.A. profession
as a whole, raising the profile of collaborative team-based care with physicians
and other national medical groups.
“I see this as an opportunity to
advance the strategic plans of both the
AAPA and NAMME,” said Wright, whose
term begins July 1, 2017. “In order to
achieve this goal, strategic partnerships
between academic institutions, constituent organizations, and community
stakeholders are paramount. Serving as
medical liaison between the AAPA and
NAMME will help advance this goal.”

Election
The Physician Assistant Education
Association (PAEA) now boasts leadership from two George Washington
University School of Medicine and
Health Sciences faculty members: Lisa
Mustone Alexander, Ed.D. ’03, P.A.-C .,
M.P.H. ’89, professor of physician assistant studies, was elected president, and
Howard Straker, P.A.-C., M.P.H., assistant
professor of physician assistant studies,
will serve a second term as secretary.
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Leadership and Service
Benjamin Blatt, M.D., professor of
medicine at the George Washington
University (GW) School of Medicine
and Health Sciences, received the 2017
Distinguished Service and Leadership
Award presented by the Association of
American Medical Colleges Northeast
Group on Educational Affairs (NEGEA).
The Distinguished Service and
Leadership Award is presented to
individuals selected by the steering
committee who offer a significant
contribution to the NEGEA initiatives
through the years. “There are other
people who have made great contributions,” Blatt said of the honor. “I’m
lucky to be the one who was selected.”
His contributions include serving in
NEGEA leadership positions, founding
several initiatives, delivering numerous
presentations, and coordinating two
annual meetings at GW.
Blatt received the award during
the 2017 NEGEA Education Meeting at
the University of Rochester School of
Medicine and Dentistry, May 6.

Mary Ottolini Receives
Lifetime Medical Education
Achievement Award
Mary Ottolini, M.D., M.P.H., vice chair
of medical education at Children’s
National Health System and professor
of pediatrics at the George Washington
University School of Medicine and
Health Sciences, received a Lifetime
Medical Education Achievement Award
from the Council on Medical Student
Education in Pediatrics (COMSEP).
COMSEP was established in 1992
with the support of the Association of
Medical School Pediatric Department
Chairs and became an independent
organization in 2015. It promotes
the importance of pediatric medical
student education.

Setting the Standard for
Safe Practices
John M. Young, D.P.S., assistant
professor of clinical research and
leadership at the George Washington
University School of Medicine
and Health Sciences, was recently
appointed to the Federation of State
Boards of Physical Therapy (FSBPT)
board of directors.
For more than 25 years, the FSBPT
has paved the way for public protection
by providing service and leadership
that promote safe physical therapy
practices. The board of directors
for the FSBPT includes members of
member boards, of which there are 53,
administrators of member boards, and
public members. Young was elected
for a one-year appointment with the
option of renewal up to 10 years.

Leading the Way
Juliet Lee, M.D., assistant professor
of surgery at the George Washington
University School of Medicine and
Health Sciences, recently joined the
ranks of the International Association of
Health Care Professionals (IAHCP) with
her upcoming inclusion in The Leading
Physicians of the World. The IAHCP, a
networking organization, is composed
of more than 30 different medical
specialties and provides members with
a platform for connecting with others
in the industry, including patients,
experts, and colleagues.

CLASS NOTES
1960s

Oscar I. Dodek Jr., M.D. ’56, J.D. ’85,
Professor Emeritus of Obstetrics and
Gynecology at the George Washington
University (GW) School of Medicine and
Health Sciences (SMHS), died March 2, 2017.

Vincent T. Devita Jr., M.D. ’61, HON.
’84, received the 2017 Yale Cancer
Center Lifetime Achievement Award.
David Henry Goodman, M.D. ’63, was
named Clinical Professor Emeritus by
the Department of Medicine at George
Washington University School of
Medicine and Health Sciences.

1970s

Paul B. Roth, M.D. ’76, FACEP, was
awarded the New Mexico Spirit of
Achievement Award by National
Jewish Health.
John Joseph Wells, M.D. ’78, was
awarded Top Doc in Phoenix magazine.

1980s

Andrea Carpenter, M.D. ’89, Ph.D.,
served as president of the Southern
Thoracic Surgical Association in 2016.
Robert C. Hendel, M.D. ’83, was
appointed as the Sidney W. and Marilyn S.
Lassen Chair in Cardiovascular Medicine,
chief, Section of Cardiology, director of
Tulane Heart and Vascular Institute.
Peter Kaufman, M.D. ’80, was
named Fellow of the American
Gastroenterology Association and also
named a Washingtonian Top Doc for
the second year.
James Longobardi, D.P.M., M.B.A.,
P.A. ’80, was elected chief of surgery,
Mercy Scripps Chula Vista, 2017–19.

1990s

Nathaniel Beers, M.D. ’95, CERT
’04, FAAP, assumed the role of CEO
of the HSC Health Care System, a
nonprofit health care organization in
Washington, D.C., in May 2017. In this
role, he oversees the HSC Pediatric
Center, both inpatient and outpatient services, HSC Home Care and

A native Washingtonian, Dodek had a
lengthy career as a physician specializing in reproductive endocrinology. At
SMHS, he served as a clinical professor of
obstetrics and gynecology for 35 years
and became Professor Emeritus in 1998.
He was the first board-certified reproductive endocrinologist in the Washington,
D.C., area, and specialized in the latest
techniques to combat infertility. In 1978,
Dodek established the Division of Reproductive Endocrinology at GW.
Dodek earned his M.D. degree from GW in 1956. He completed his residency
training in obstetrics and gynecology at Mount Sinai Medical Center and served a
fellowship at the Worcester Foundation for Experimental Biology. In 1985, Dodek
graduated from GW Law School and became a member of the Order of the Coif,
an honor society for United States law graduates.
Dodek had many civic and philanthropic interests and was a passionate advocate
for human rights and women’s issues. The Kane-King-Dodek Obstetrical Honor
Society was established to recognize the leaders in the department of obstetrics
and gynecology at GW. The Oscar I. Dodek and Mildred S. Dodek and Joan B. and
Oscar I. Dodek Jr., M.D. ’56, J.D. ’85, professorship, established in 1982, has been
held by a notable list of SMHS leaders, including the current Dodek Professor and
Chair, Nancy D. Gaba, M.D. ’93, RESD ’97, FACOG, who was installed Oct. 8, 2014.

residential services, health services for
children with special health care needs,
the Medicaid managed care provider
for children and youth with disabilities
in D.C., and the HSC Foundation.

Elizabeth Ann Ignacio, M.D.,
RESD ’98, served as president of the
Hawaii Radiological Society, state
chapter of American College of
Radiology, 2016–17.

Kendalle Cobb, M.D. ’96, received the
Chief of Staff Award from the Cleveland
Clinic. The $25,000 grant will be used to
explore the challenges and successes
the Cleveland Clinic faces in creating a
culture of diversity and inclusion.

John G. Pattaras, M.D. ’92, RESD ’99,
associate professor of urology at
Emory University School of Medicine,
was named Emory’s James C. Kennedy
Chair in Prostate Surgery. He is also
the chief of Emory urology services at
Saint Joseph’s Hospital and director of
minimally invasive surgery.

Erin Hogan, B.S. ’98, Emergency
Medical Services, was promoted
to philanthropic market executive,
Southeast U.S., U.S. Trust, Bank of
America Private Wealth Management.
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CLASS NOTES
Edgar Ratilla, CERT ’95, Health Science
Laboratory Technology, obtained the
American Society for Quality’s certified manager of quality/organizational
excellence designation.
John S. Symington, M.D., RESD ’91,
became president of the INOVA Mt.
Vernon Hospital staff.

2000s

Petros Carvounis, M.D., RESD ’05, was
recognized as a Top Doctor in ophthalmology in Houstonia magazine.
Brett F. Holt, M.D. ’06, RESD ’08,
was featured in the International
Association of Health Care
Professionals urologist publication The
Leading Physicians of the World. Holt is
a board-certified urologist specializing
in urinary tract disease and the male
reproductive system, and is a robotic
surgery expert.
Hope T. Jackson, M.D. ’09, RESD ’16,
CERT ’14, minimally invasive surgery
foregut/bariatric surgery fellow at
the University of Washington Medical
Center, was selected as one of the 2017
National Minority Quality Forum 40
Under 40 Leaders in Minority Health.
Supriya Jagannath-Vanguri, M.D.
’02, B.A. ’98, serves as an oral board
examiner for the American Board of
Anesthesiology.
Lt. Commander Ian Marks, P.A. ’00,
CERT ’00, graduated from the United
States Naval War College in the fall of
2016. He is the first Coast Guard physician assistant to earn a diploma from
the Naval War College and is currently
serving as the senior medical officer
for the U.S.C.G. clinic in the port of
Los Angeles.
Thomas Maruna, B.S. ’09, A.A. ’06,
CERT ’05, Clinical Laboratory Sciences,
received the Junior Officer Medical
Laboratory Scientist of the Year
Award from the United States Public
Health Service.
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Louis Miller, M.D. ’03, B.A. ’99,
received the New York University
Department of Medicine Teacher of the
Year award.
Lauryn Rochlen, M.D. ’04, was selected
to serve as a board examiner for the
American Board of Anesthesiology.

IN MEMORIUM
James C. Bruce, M.D. ’51, RESD ’55
Arnold L. Case, M.D. ’60
William Chin-Lee, M.D. ’47
William S. Costello, CERT ’95
Paul R. Dinsmore, M.D. ’58

Jaspal Singh, M.D. ’06, B.A. ’02, was
named co-director of the recently
opened Weill Cornell Medicine Center
for Comprehensive Spine Care in
New York City. Singh also serves as
the medical director of outpatient
faculty practice in the Department of
Rehabilitation Medicine at Weill Cornell
Medical College.

Morris Feitel, M.D. ’57

Jennifer M. Stonebrook, M.S. ’09,
Health Sciences, earned certification as
a hospice and palliative care administrator through the Canadian Hospice
Palliative Care Association.

John Norton Robinson, M.D. ’63

2010s

A. James Watt, M.D. ’71

Megan Evans, M.D. ’11, was appointed
assistant professor at Tufts Medical
School and associate program director
of the Tufts OB/GYN residency program.
Pooja Lakshmin, M.D., RESD ’16,
joined the faculty of the George
Washington University School of
Medicine and Health Sciences
Department of Psychiatry and
Behavioral Sciences as an assistant
professor. She specializes in reproductive psychiatry and women’s
mental health.
Sarah R. Miller, D.P.T. ’11, was named
as a fellow at the American Academy of
Orthopedic Manual Physical Therapy.
Grace A. Montenegro, M.D., RESD
’11, earned board certification from
the American Board of Colon and
Rectal Surgery.
Resmi Premji, M.D., FEL ’16, recently
earned board certification in endocrinology, diabetes, and metabolism.

Lynn D. George, M.D. ’56, B.A. ’53
Walter E. Goozh, M.D. ’57, B.A. ’54
Stephen B. Hiltabidle, M.D. ’55, RESD ’59
Frank Mate Jr., M.D. ’56
John G. McGregor Jr., M.D. ’53
Mazhar Rishi, M.D., RESD ’90

Dennis D. Shepard, M.D. ’63
Harold H. Shively, M.D. ’65
Nelson P. Trujillo, M.D., RESD ’65

Emily Wilson, P.A.-C. ’91
Jean L. Fourcroy-Behr, M.D., Ph.D.,
RESD ’79, M.P.H., died in October
2016. Fourcroy-Behr was the first
woman admitted to the George
Washington University School of
Medicine and Health Sciences
urology residency program. In 1981,
Fourcroy-Behr became only the fifth
woman in the country to earn board
certification in urology.
In 2013, in recognition of her fierce
determination and her guidance as
a role model for women entering the
field of urology, SMHS established
the Jean L. Fourcroy-Behr, M.D.,
Research Award, thanks to a generous gift from Fourcroy-Behr and
her husband Armin Behr.
“I hope it will encourage more residents to take an interest in research,
and more faculty and others to be
supportive,” said Fourcroy-Behr at
the time.

IN DEVELOPMENT

S

cholarships for our
medical and health
sciences students
remain our most
important priority for
fundraising as we close out
the fiscal year on June 30.
Our Adopt-a-Doc scholarship donors have expressed
personal satisfaction from
giving through the program
because it offers them an
opportunity to connect with
their sponsored students.
The Adopt-a-Doc program
provides $5,000 per year over
four years through an annual
pledge payment, which helps
make a small, but meaningful, dent in the debt load
upon graduation.
Students in the physician assistant, physical therapy, and other health
sciences programs face similar debt challenges. We are committed to alleviating
their burdens as well.
Any of our development officers can discuss our programs with you, and
you can find information on our website: smhs.gwu.edu/give. We invite you to
look into it.
Already this year, the George Washington University School of Medicine
and Health Sciences (SMHS) has benefited from larger contributions to the
Power & Promise scholarship fund, which provides aid to students with
financial need. This spring, we received a nearly half-million-dollar bequest
from the estate of a grateful alumnus. Gifts of all sizes and the income generated
by endowed funds are the lifeblood of our scholarship program. We are very
grateful to the generous GW donors who have joined us in the effort to help
SMHS students graduate with less debt, and we invite everyone to join this
important cause.
Sincerely,

Dennis Narango, M.A., CFRE
Associate Dean, SMHS and Associate Vice President for
GW Medicine Development and Alumni Relations
If you are 70 ½ or older, you can take advantage of a simple way to benefit the GW School
of Medicine and Health Sciences and receive tax benefits in return. You can give up to
$100,000 annually from your IRA directly to SMHS without having to pay income taxes
on the money. These gifts count toward your IRA’s minimum distribution requirements
and benefit you regardless of whether you itemize deductions on your income tax returns.
Visit gwu.planmylegacy.org/ira-charitable-rollover for more information.

Board of Advisors
Lara S. Oboler, M.D. ’95, Chair
Cardiology; Lenox Hill Heart & Vascular Institute
Gary M. Abramson
Partner, the Tower Companies
Christopher L. Barley, M.D. ’93
Internal Medicine; Clinical Assistant Professor of
Medicine, Cornell/Weill School of Medicine
Constance Urciolo Battle, M.D. ’67, FAAP
Pediatrics and Public Health
Luther W. Brady Jr., M.D. ’48, HON. ’04, B.A. ’46,
A.A. ’44
Radiation Oncology; Affiliated Faculty, Department
of Radiation Oncology, Drexel University College of
Medicine; GW Emeritus Trustee
Elizabeth L. Cobbs, M.D. ’81, RESD ’84
Professor of Medicine, GW School of Medicine and
Health Sciences; Chief, Department of Geriatrics,
Extended Care, and Palliative Care, GW Medical
Faculty Associates
Carlos R. Diaz, M.D. ’72, RESD ’75
President and Owner, Aeromedical Services
Daniel Ein, M.D., FACP, FAAAAI, FACAAI
Allergy, Asthma, and Immunology; Clinical Professor
of Medicine, GW School of Medicine and Health
Sciences; Director, Allergy & Sinus Center, GW
Medical Faculty Associates
Thomas E. Flynn, M.D. ’86
Ophthalmology; Ellsworth Uveitis & Retina Care
Jeanne G. Holzgrefe, M.D. ’96, Ph.D., M.P.H.
Psychiatry; Chevy Chase Psychiatric Services;
Assistant Clinical Professor of Psychiatry and
Behavioral Sciences, GW School of Medicine and
Health Sciences
Floyd Alexander Katske, M.D. ’76, RESD ’77
Urology; Clinical Assistant Professor of Urology,
David Geffen School of Medicine, UCLA
Kerry L. Kuhn, M.D. ’73, RESD ’77, B.A. ’70, FACOG
Obstetrics and Gynecology; Private Practice; Senior
Vice President of VitalMD
Gerald S. Lazarus, M.D. ’63
Dermatology; Professor of Dermatology, Johns
Hopkins University; Former Member, GW Board
of Trustees
John C. Pan, M.D. ’70, RESD ’74
Obstetrics and Gynecology; Founder, Center for
Integrative Medicine, GW School of Medicine and
Health Sciences
Smita H. Patel, M.D., DFAPA
Psychiatry; Assistant Clinical Professor of Psychiatry
and Behavioral Science, GW School of Medicine and
Health Sciences
Rakesh C. Sahni, M.D.
Cardiology; Maryland Cardiology Associates
Mark W. Surrey, M.D. ’72, FACOG, FACS
Obstetrics and Gynecology and Reproductive
Endocrinology; Professor and Clinical Director,
Reproductive Surgery, UCLA; Co-Founder and
Medical Director, Southern California Reproductive
Center
The SMHS Board of Advisors offers the dean of the School of Medicine
and Health Sciences recommendations on strategic priorities and important issues for the school, and provides generous support and advocacy.

NON-PROFIT ORG.
U.S. POSTAGE
PAID
KENT, OH
PERMIT NO. 15

OFFICE OF COMMUNICATIONS AND MARKETING

2600 Virginia Ave., NW
Suite 329
Washington, DC 20036

Cultivating Strengths Within Health Sciences
Senior Associate Dean for Health Sciences Reamer L. Bushardt, Pharm.D., P.A.-C., DFAAPA, discusses how his background and
experiences — from growing up as the son of a pharmacist in a quiet South Carolina community to his years as professor and
chair of the Department of Physician Assistant Studies at Wake Forest Baptist Medical Center’s School of Medicine — will shape
his efforts to support the health sciences programs at GW. Read more on page 12.

